BIOCON.BOBIOCON.BOBSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank7
3Y CAGR-5.0%
5Y CAGR-4.2%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-5.0%/yr
vs +4.5%/yr prior
5Y CAGR
-4.2%/yr
Consistent
Acceleration
-9.5pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive declineStable
PeriodValueYoY Change
202520.47%-7.7%
202422.17%-6.8%
202323.78%-0.5%
202223.91%+3.4%
202123.13%-8.6%
202025.31%+0.3%
201925.24%+25.8%
201820.06%-20.5%
201725.23%+10.7%
201622.79%-